Adamis Pharmaceuticals (NASDAQ:ADMP)

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) was down 17% in pre-market after the company announced its Q3 2021 financial results and offered

Specialty biopharmaceutical firm focusing on developing and commercialising products in therapeutic areas, Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) on July 19, 2021

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) is moving in range after the company announced the re-election of Howard C. Birndorf, Dennis Carlo,